Search Results

Filter
  • 1-10 of  140,629 results for ""Depressive Disorder""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication.

  • Authors : Ramli FF; Psychopharmacology Research Group, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.; Oxford Health NHS Foundation Trust, Oxford, UK.

Subjects: Isoindoles* ; Organoselenium Compounds*/Organoselenium Compounds*/Organoselenium Compounds*/pharmacology ; Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/drug therapy

  • Source: Translational psychiatry [Transl Psychiatry] 2024 May 07; Vol. 14 (1), pp. 200. Date of Electronic Publication: 2024 May 07.Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community.

  • Authors : Beaglehole B; Psychological Medicine, University of Otago, Christchurch, New Zealand .; Porter R

Subjects: Ketamine*/Ketamine*/Ketamine*/administration & dosage ; Ketamine*/Ketamine*/Ketamine*/therapeutic use ; Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/therapy

  • Source: BMJ open [BMJ Open] 2024 May 01; Vol. 14 (5), pp. e084844. Date of Electronic Publication: 2024 May 01.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Safety and efficacy of repetitive stimulation of the left dorsolateral prefrontal cortex using transcranial focused ultrasound in treatment-resistant depressed patients: A non-inferiority randomized controlled trial protocol.

  • Authors : Dos Santos Alves Maria G; Department of Psychiatry, School of Medicine, Federal University of Minas Gerais, Professor Alfredo Balena Avenue, 190, Belo Horizonte, Minas Gerais 30.130-100, Brazil; Center of Technology in Molecular Medicine, Professor Alfredo Balena Avenue, 190, Belo Horizonte, Minas Gerais 30.130-100, Brazil.

Subjects: Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/therapy ; Dorsolateral Prefrontal Cortex*/Dorsolateral Prefrontal Cortex*/Dorsolateral Prefrontal Cortex*/physiology; Humans

  • Source: Asian journal of psychiatry [Asian J Psychiatr] 2024 May; Vol. 95, pp. 103994. Date of Electronic Publication: 2024 Mar 16.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101517820 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Dialectical Behavior Therapy as an intervention for Treatment Resistant Depression in adults: A protocol for systematic review and meta-analysis.

  • Authors : Junkes L; Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.; Gherman BR

Subjects: Systematic Reviews as Topic* ; Meta-Analysis as Topic* ; Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/therapy

  • Source: PloS one [PLoS One] 2024 May 22; Vol. 19 (5), pp. e0303967. Date of Electronic Publication: 2024 May 22 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Efficacy of Esketamine among patients with treatment resistant depression in a 'real world' health-care setting in Israel.

  • Authors : Dvorak L; Shalvata Mental Health Center, Hod Hasharon, Israel; Tel Aviv University, Faculty of Medicine, Tel Aviv, Israel.

Subjects: Ketamine*/Ketamine*/Ketamine*/administration & dosage ; Ketamine*/Ketamine*/Ketamine*/pharmacology ; Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/drug therapy

  • Source: Journal of psychiatric research [J Psychiatr Res] 2024 Jun; Vol. 174, pp. 66-72. Date of Electronic Publication: 2024 Apr 10.Publisher: Pergamon Press Country of Publication: England NLM ID: 0376331 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Treatment resistant late-life depression: A narrative review of psychosocial risk factors, non-pharmacological interventions, and the role of clinical phenotyping.

  • Authors : Patrick RE; Department of Neuropsychology, McLean Hospital, Belmont, MA, United States of America; Division of Geriatric Psychiatry, McLean Hospital, Belmont, MA, United States of America

Subjects: Phenotype* ; Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/therapy; Humans

  • Source: Journal of affective disorders [J Affect Disord] 2024 Jul 01; Vol. 356, pp. 145-154. Date of Electronic Publication: 2024 Apr 07.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7906073 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Special Populations: Treatment-Resistant Depression in Children and Adolescents.

  • Authors : Ayvaci ER; Department of Psychiatry, UT Southwestern Medical Center, 6300 Harry Hines Boulevard, Dallas, TX 75235, USA. Electronic address: https://twitter.com/AyvaciRabia.; Croarkin PE

Subjects: Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/classification ; Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/diagnosis ; Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/drug therapy

  • Source: The Psychiatric clinics of North America [Psychiatr Clin North Am] 2023 Jun; Vol. 46 (2), pp. 359-370. Date of Electronic Publication: 2023 Mar 15.Publisher: W B Saunders Country of Publication: United States NLM ID: 7708110 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.

  • Authors : Anand A; From the Department of Psychiatry, Mass General Brigham, and Harvard Medical School - both in Boston (A.A.); Baylor College of Medicine (S.J.M., A.A.A.-A., S.I., L.C.C.) and Michael E. DeBakey Veterans Affairs Medical Center, Houston (S.J.M., A.A.A.-A., S.I.), and the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (M.K.J.) - all in Texas

Subjects: Electroconvulsive Therapy*/Electroconvulsive Therapy*/Electroconvulsive Therapy*/adverse effects ; Ketamine*/Ketamine*/Ketamine*/administration & dosage ; Ketamine*/Ketamine*/Ketamine*/adverse effects

  • Source: The New England journal of medicine [N Engl J Med] 2023 Jun 22; Vol. 388 (25), pp. 2315-2325. Date of Electronic Publication: 2023 May 24.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.

  • Authors : Rosenblat JD; Braxia Health, Canadian Rapid Treatment Centre of Excellence (CRTCE), Braxia Scientific, Mississauga, ON, Canada; University of Toronto, Toronto, ON, Canada. Electronic address: .

Subjects: Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/drug therapy ; Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/chemically induced ; Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/drug therapy

  • Source: Med (New York, N.Y.) [Med] 2024 Mar 08; Vol. 5 (3), pp. 190-200.e5. Date of Electronic Publication: 2024 Feb 14.Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial.

  • Authors : Zolghadriha A; Department of Psychiatry, Shahid Beheshti Hospital, Zanjan University of Medical Sciences, Zanjan, Iran. .; Anjomshoaa A

Subjects: Ketamine*/Ketamine*/Ketamine*/therapeutic use ; Ketamine*/Ketamine*/Ketamine*/administration & dosage ; Suicidal Ideation*

  • Source: BMC psychiatry [BMC Psychiatry] 2024 May 07; Vol. 24 (1), pp. 341. Date of Electronic Publication: 2024 May 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X

Record details

×
  • 1-10 of  140,629 results for ""Depressive Disorder""